Priti Patel Selected Research

Vitamin K

1/2020

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Priti Patel Research Topics

Disease

11	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2019
7	Neoplasms (Cancer) 03/2022 - 01/2020
5	Disease Progression 01/2022 - 01/2018
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2022 - 01/2018
2	Carcinoma (Carcinomatosis) 03/2022 - 10/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 10/2021
2	Infections 11/2021 - 01/2020
2	Cough 01/2021 - 01/2019
2	Headache (Headaches) 01/2021 - 01/2019
2	Diarrhea 01/2021 - 01/2019
2	Fatigue 10/2020 - 08/2011
1	Critical Illness (Critically Ill) 10/2022
1	Ulcer 10/2022
1	Squamous Cell Carcinoma of Head and Neck 03/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Atrial Flutter (Flutter, Atrial) 11/2021
1	Atrial Fibrillation 11/2021
1	Stomach Neoplasms (Stomach Cancer) 07/2021
1	Dizziness (Lightheadedness) 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Contusions 01/2021
1	Hairy Cell Leukemia 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 10/2020
1	Anemia 10/2020
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2020
1	Adenocarcinoma 01/2020
1	Aspergillosis 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Glioma (Gliomas) 01/2020
1	Lymphocytosis 01/2020
1	Mucormycosis 01/2020
1	Neutropenia 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Multiple Myeloma 01/2016
1	Osteonecrosis (Kienbock's Disease) 04/2015
1	Pain (Aches) 11/2013
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 11/2013
1	Disease Susceptibility (Diathesis) 10/2012
1	Hemophilia B (Haemophilia B) 10/2012
1	Hemorrhage 10/2012
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2012
1	Bacterial Meningitis 01/2012
1	Testicular Neoplasms (Testicular Cancer) 01/2012
1	Hypertriglyceridemia 08/2011
1	Hand-Foot Syndrome 08/2011
1	Hypertension (High Blood Pressure) 08/2011
1	Hyperglycemia 08/2011
1	Kidney Neoplasms (Kidney Cancer) 08/2011

Drug/Important Bio-Agent (IBA)

22	acalabrutinibIBA 10/2022 - 01/2018
14	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022 - 01/2018
4	ibrutinibIBA 01/2022 - 01/2019
3	pembrolizumabIBA 03/2022 - 01/2020
2	obinutuzumabIBA 01/2022 - 01/2020
1	Proton Pump InhibitorsIBA 10/2022
1	N- (1- (7- fluoro- 2- (pyridin- 2- yl)quinolin- 3- yl)ethyl)- 9H- purin- 6- amineIBA 01/2022
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 07/2021
1	immunotoxin HA22IBA 01/2021
1	PlatinumIBA 10/2020
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Programmed Cell Death 1 ReceptorIBA 10/2020
1	Alanine Transaminase (SGPT)IBA 10/2020
1	Voriconazole (Vfend)FDA LinkGeneric 01/2020
1	idelalisibIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Bendamustine Hydrochloride FDA Link 01/2020
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2020
1	Chlorambucil (Leukeran)FDA Link 01/2020
1	Immunoglobulin Variable RegionIBA 01/2020
1	Vitamin K FDA Link 01/2020
1	Warfarin (Coumadin)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Proto-Oncogene Proteins c-fynIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	carfilzomibIBA 01/2016
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	Proteasome InhibitorsIBA 01/2016
1	Diphosphonates (Bisphosphonates)IBA 04/2015
1	Carisoprodol (Soma)FDA LinkGeneric 11/2013
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 10/2012
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2012
1	Contrast MediaIBA 01/2012
1	Bevacizumab (Avastin)FDA Link 08/2011
1	MTOR InhibitorsIBA 08/2011
1	temsirolimus FDA Link 08/2011
1	pazopanib FDA Link 08/2011
1	Sunitinib (Sutent)FDA Link 08/2011
1	Sorafenib (BAY 43-9006)FDA Link 08/2011
1	Everolimus FDA Link 08/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011

Therapy/Procedure

7	Therapeutics 03/2022 - 08/2011
2	Immunotherapy 10/2020 - 01/2020
1	Debridement 01/2020
1	Brachytherapy 11/2013
1	Catheters 10/2012
1	Spinal Injections 01/2012